title: The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity.
authors.forename: Marco
authors.initials: M
authors.lastname: De Santis
authors.forename: Gianluca
authors.initials: G
authors.lastname: Straface
authors.forename: Annafranca
authors.initials: A
authors.lastname: Cavaliere
authors.forename: Elena
authors.initials: E
authors.lastname: Nobili
authors.forename: Allesandro
authors.initials: A
authors.lastname: Caruso
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000022:Abortion, Spontaneous; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D011307:Drug Prescriptions / Q000592:standards; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007558:Italy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced; D014212:Tretinoin / Q000009:adverse effects*
chemical_list: D003879:Dermatologic Agents; D014212:Tretinoin; D015474:Isotretinoin